ATE119386T1 - Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung. - Google Patents

Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.

Info

Publication number
ATE119386T1
ATE119386T1 AT90913658T AT90913658T ATE119386T1 AT E119386 T1 ATE119386 T1 AT E119386T1 AT 90913658 T AT90913658 T AT 90913658T AT 90913658 T AT90913658 T AT 90913658T AT E119386 T1 ATE119386 T1 AT E119386T1
Authority
AT
Austria
Prior art keywords
producing
lotion
external analgesic
camphor
analgesic lotion
Prior art date
Application number
AT90913658T
Other languages
English (en)
Inventor
Jeffery W Ivy
Curtis E Payne
Original Assignee
Jeffery W Ivy
Curtis E Payne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeffery W Ivy, Curtis E Payne filed Critical Jeffery W Ivy
Application granted granted Critical
Publication of ATE119386T1 publication Critical patent/ATE119386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90913658T 1989-09-12 1990-08-29 Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung. ATE119386T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/406,072 US5013726A (en) 1989-09-12 1989-09-12 External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion

Publications (1)

Publication Number Publication Date
ATE119386T1 true ATE119386T1 (de) 1995-03-15

Family

ID=23606433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913658T ATE119386T1 (de) 1989-09-12 1990-08-29 Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.

Country Status (9)

Country Link
US (1) US5013726A (de)
EP (1) EP0443007B1 (de)
AT (1) ATE119386T1 (de)
CA (1) CA2025078C (de)
DE (1) DE69017654T2 (de)
DK (1) DK0443007T3 (de)
ES (1) ES2072447T3 (de)
HK (1) HK48897A (de)
WO (1) WO1991004010A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118240C2 (de) * 1991-06-04 1997-08-14 Marianne Seiler Tonisierendes Mittel
US5223257A (en) * 1992-03-11 1993-06-29 Vasu Arora Topical composition for relieving aches and pains
US5446025A (en) * 1992-06-12 1995-08-29 Abbott Laboratories Formulations and method of the percutaneous administration of leuprolide
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition
WO1994001083A1 (en) * 1992-07-13 1994-01-20 Shiseido Company, Ltd. Composition for dermatologic preparation
US5888984A (en) 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
UA10208A (uk) * 1994-08-03 1996-12-25 Жанна Прокопівна Гудзенко Дерматологічний косметичний засіб
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
AU1612297A (en) * 1997-02-05 1998-08-26 Au Pharmaceuticals, Inc Composition for the treatment of haemorrhoids and other anorectal inflammations
US6572871B1 (en) * 1999-01-06 2003-06-03 W. Edward Church Pain treatment method and apparatus using heating wrap and analgesic cream
US20040073258A1 (en) * 1999-01-06 2004-04-15 Church W. Edward Body tissue and skin treatment method using pulsing heating pad and topical cream
WO2000042848A1 (en) * 1999-01-19 2000-07-27 Bj Farmacéutica Ltda. Medicinal composition and its process of preparation
ATE361082T1 (de) 1999-02-01 2007-05-15 Dermal Res Lab Inc Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US8900607B1 (en) 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2009089494A2 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
US8785160B2 (en) * 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2429559A4 (de) * 2009-05-08 2013-08-14 Allmedic Pty Ltd Behandlung von schmerzen und/oder entzündungen sowie behandlung und verhinderung von haut- oder schleimhauterkrankungen oder -leiden
EP2451274B1 (de) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
EP3125905A4 (de) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Verfahren und zusammensetzungen für mikrobiomveränderung
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644620A (en) * 1970-05-22 1972-02-22 William J Vittone Antiphlogistic
FR2184525A2 (en) * 1972-05-19 1973-12-28 Sotil Marie Lou Se Skin treatment compsn - contg particles of pure gold and vegetable animal mineral matl
DE3009143A1 (de) * 1980-03-10 1981-10-01 Hans Dr Bauersfeld Arzneimittelzubereitung und deren verwendung
US4784849A (en) * 1983-08-15 1988-11-15 Tutsky Ronald J Skin care and shaving compositions
HUT37342A (en) * 1983-10-17 1985-12-28 Caola Kozmetikai Process for production of preparatives for medical cosmetics
FR2554715B1 (fr) * 1983-11-10 1987-07-24 Roullier Anne Gamme de produits cosmetiques contenant des particules de poudre d'or
US4657763A (en) * 1985-09-03 1987-04-14 Michael Ebert Combined chrysotherapeutic agents for autoimmune diseases
US4725438A (en) * 1986-05-29 1988-02-16 Leazer Billie S Aloe vera ointment
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US4883664A (en) * 1987-06-29 1989-11-28 Mary Sharkey Medicinal salve

Also Published As

Publication number Publication date
CA2025078A1 (en) 1991-03-13
CA2025078C (en) 1996-01-30
EP0443007B1 (de) 1995-03-08
ES2072447T3 (es) 1995-07-16
HK48897A (en) 1997-04-25
DE69017654T2 (de) 1996-01-18
DK0443007T3 (da) 1995-05-22
EP0443007A4 (en) 1993-03-03
DE69017654D1 (de) 1995-04-13
WO1991004010A1 (en) 1991-04-04
EP0443007A1 (de) 1991-08-28
US5013726A (en) 1991-05-07

Similar Documents

Publication Publication Date Title
ATE119386T1 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
EP0962225A3 (de) Verwendung von Phentolamin zur Herstellung eines Arzneimittels zur Behandlung von erektiler Funktionsstörung
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DE68912459D1 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
BR0215118A (pt) Solução para ingestão via oral, método para a obtenção uma solução para ingestão via oral suplementada com ketoprofeno e uso de uma solução aquosa de ketoprofeno
DE602004017888D1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
DE60036131D1 (de) Zusammensetzungen zur Gewebesenisibilisierung weiblicher Personen und Verfahren und Vorrichtung zur Verabreichung dieser Verbindungen
WO1998025573A3 (en) The use of celastrol to treat alzheimer's disease
DE69716223T2 (de) Vorrichtung zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung
DE58903964D1 (de) Fluessige orale formulierung.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE107852T1 (de) Badezusatz und dessen verwendung.
DE69626312D1 (de) Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
SE9904863D0 (sv) New use
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
ATE28384T1 (de) Medizinisches verfahren und zubereitung.
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee